Bad Blood Secrets and Lies in a Silicon Valley Startup

The full inside story of the breathtaking rise and shocking collapse of a multibillion dollar startup by the prize winning journalist who first broke the story and pursued it to the end in the face of pressure and threats from the CEO and her lawyersIn 2014 Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs a brilliant Stanford dropout whose startup unicorn promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier Backed by investors such as Larry Ellison and Tim Draper Theranos sold shares in a fundraising round that valued the company at 9 billion putting Holmes's worth at an estimated 47 billion There was just one problem The technology didn't workFor years Holmes had been misleading investors FDA officials and her own employees When Carreyrou working at The Wall Street Journal got a tip from a former Theranos employee and started asking questions both Carreyrou and the Journal were threatened with lawsuits Undaunted the newspaper ran the first of dozens of Theranos articles in late 2015 By early 2017 the company's value was zero and Holmes faced potential legal action from the government and her investors Here is the riveting story of the biggest corporate fraud since Enron a disturbing cautionary tale set amid the bold promises and gold rush frenzy of Silicon Valley


10 thoughts on “Bad Blood Secrets and Lies in a Silicon Valley Startup

  1. SE IÞ~ mdI="1V阥Q ٲΏBF[nwV|A7pzSܨ*P}F˶j!Xuw0qUj ,^ڃZ^yS U}5뻶۟#jiDQ*;'dj;[%LX욎8GsѮDҚu>D% !A"01#2B@@B9jkpw'cNkJhcj5P#5{R3ѹ}.ɭ+P6͸R7Kn J\K!ХiHDf926J$DT"}>1qN7*'h,^4g~NMBBC PwZ4:\AR1+HQbva1rߙ jTܲ.y.9⍾j .D8:Cm;Jzr룄i*ґfܰ*rVyh TaT|=T3ѝhEtZ8v1J햰az5һO"(įu ǽ'̢7Nժ%lU1/zgyu@ +sg!LR9hftz-#B 9'nBйz~noy${Ob@ZE)!Ū(31MePJP"ch0"-k"&IΈ'GBz5t14TS6""hSj,K_#ug/sqpt^ i}E71-tUNzdE'p;bo^Czp%,uH=jX2Xę 0QGѓJ B6&ZM"TJ7e (|JQEJXȄKWRsWz90,Ѻ] ˅]n)"e)T b2QJ]7[6v܈DKlM[y 5e[DNFjUW.#uڳ.D/eW* **@T1.ЫA]^'I4LqZ/ءo' nl;j]Hr[F॥::ܺH o F8tjVSFff;bec)&F•FY+a'TZ$Qd :pм:"Mʼn.4ؒF$$& }=p%m0,U$!tmm@  DEBFG A%JM|McrCqU:'5>jCr` Xq.PBAx'Qlߠ_:p8p4 n {"j TH09&Y%D@W]݆@n82d$=o|EFGBqk4RdfUECܛ!R`p a u.ֽD=6UtA@ɒu ?X]> LRC=xU:m<`/=qZrCA;6r{۰_K}re O :BǯS0cjX+e@XAB utd!29aEC9'0ڧH iSЖQkfu**Z$j x{\dAq* _rmbԃol,]+MlU.5߸o}2 ;"Qіo%Xf.nTffM))^bG458[";V+apV,brq_Pӻdc*IK(fa NӘF1C1B`>]SH`'E]^ K5LN.&DjgIDu2䖡oF-;,dHB|@ 0p@p!%&7*/h $S| r\]*L._|)D8>Aul Y'3R7&]#1`sȪRBAۺXfL *Wc2fCz XvDDD@IFɊG I ?FLG녆Z}yb'Q+Y4=ѧ6ڟ69t2E;+o%<2lRXIأ^bO֜OۋIg+!@Lub @3/ ݢ7EA&o^JúPq,tJ< BiE+L" srcset=">d`l$$( ( ,,$,(,,,8@0(,4L\T@PSE IÞ~ mdI="1V阥Q ٲΏBF[nwV|A7pzSܨ*P}F˶j!Xuw0qUj ,^ڃZ^yS U}5뻶۟#jiDQ*;'dj;[%LX욎8GsѮDҚu>D% !A"01#2B@@B9jkpw'cNkJhcj5P#5{R3ѹ}.ɭ+P6͸R7Kn J\K!ХiHDf926J$DT"}>1qN7*'h,^4g~NMBBC PwZ4:\AR1+HQbva1rߙ jTܲ.y.9⍾j .D8:Cm;Jzr룄i*ґfܰ*rVyh TaT|=T3ѝhEtZ8v1J햰az5һO"(įu ǽ'̢7Nժ%lU1/zgyu@ +sg!LR9hftz-#B 9'nBйz~noy${Ob@ZE)!Ū(31MePJP"ch0"-k"&IΈ'GBz5t14TS6""hSj,K_#ug/sqpt^ i}E71-tUNzdE'p;bo^Czp%,uH=jX2Xę 0QGѓJ B6&ZM"TJ7e (|JQEJXȄKWRsWz90,Ѻ] ˅]n)"e)T b2QJ]7[6v܈DKlM[y 5e[DNFjUW.#uڳ.D/eW* **@T1.ЫA]^'I4LqZ/ءo' nl;j]Hr[F॥::ܺH o F8tjVSFff;bec)&F•FY+a'TZ$Qd :pм:"Mʼn.4ؒF$$& }=p%m0,U$!tmm@  DEBFG A%JM|McrCqU:'5>jCr` Xq.PBAx'Qlߠ_:p8p4 n {"j TH09&Y%D@W]݆@n82d$=o|EFGBqk4RdfUECܛ!R`p a u.ֽD=6UtA@ɒu ?X]> LRC=xU:m<`/=qZrCA;6r{۰_K}re O :BǯS0cjX+e@XAB utd!29aEC9'0ڧH iSЖQkfu**Z$j x{\dAq* _rmbԃol,]+MlU.5߸o}2 ;"Qіo%Xf.nTffM))^bG458[";V+apV,brq_Pӻdc*IK(fa NӘF1C1B`>]SH`'E]^ K5LN.&DjgIDu2䖡oF-;,dHB|@ 0p@p!%&7*/h $S| r\]*L._|)D8>Aul Y'3R7&]#1`sȪRBAۺXfL *Wc2fCz XvDDD@IFɊG I ?FLG녆Z}yb'Q+Y4=ѧ6ڟ69t2E;+o%<2lRXIأ^bO֜OۋIg+!@Lub @3/ ݢ7EA&o^JúPq,tJ< BiE+L" class="avatar avatar-100 photo amp-wp-enforced-sizes" height="100" width="100" layout="intrinsic"> says:

    I don’t read a lot of page turners I often find myself unable to put a book down—but they’re not the kinds of books that would keep most people glued to their chairs Still I recently found myself reading a book so compelling that I couldn’t turn away Bad Blood Secrets and Lies in a Silicon Valley Startup by John Carreyrou details the rise and fall of Theranos If you aren’t familiar with the Theranos story here’s the short version the company promised to quickly give you a complete picture of your health using only a small amount of blood Elizabeth Holmes founded it when she was just 19 years old and both she and Theranos quickly became the darlings of Silicon Valley She gave massively popular TED talks and appeared on the covers of Forbes and FortuneBy 2013 Theranos was valued at nearly 10 billion and even partnered with Walgreens to put their blood tests in stores around the country The problem? Their technology never worked It never came close to working But Holmes was so good at selling her vision that she wasn’t stopped until after real patients were using the company’s “tests” to make decisions about their health She and her former business partner are now facing potential jail time on fraud charges and Theranos officially shut down in AugustThe public didn’t know about Theranos’ deception until Carreyrou broke the story as a reporter at the Wall Street Journal Because he was so integral to the company’s demise Bad Blood offers a remarkable inside lookSome of the details he shares are—for lack of a better word—insane Holmes would invite prospective investors to the lab so they could get their blood tested on a Theranos machine The device had been programmed to show a really slow progress bar instead of an error message When results didn’t come back right away Holmes sent the investors home and promised to follow up with resultsAs soon as they left an employee would remove the blood sample from the device and transfer it to a commercial blood analyzer Her investors got their blood tested by the same machines available in any lab in the country and they had no ideaThere’s a lot Silicon Valley can learn from the Theranos mess To start a company needs relevant experts on its board of directors The Theranos board had some heavy hitters—including several former Cabinet secretaries and senators—but for most of the company’s existence none of them had any expertise in diagnostics If they had they might have noticed the red flags a lot soonerHealth technology requires a different approach than other kinds of technology because human lives are on the line Carreyrou writes a lot about how Holmes idolized Steve Jobs and his unwillingness to compromise on his vision That approach is okay for consumer electronics—if a new phone doesn’t work as promised no one gets hurt—but it’s irresponsible for a health company Holmes pushed a vision of what Theranos could be not what it actually was and people suffered as a result Bad Blood is also a cautionary tale about the virtues of celebrity On the surface Holmes was everything Silicon Valley loves in a CEO charismatic and convincing with a memorable personal story made for magazine profiles There’s nothing wrong with that on its own A rock star CEO can be a huge boon for a startup But you can’t let fame become the most important thingTheranos is the worst case scenario of what happens when a CEO prioritizes personal legacy above all else—but I hope that people don’t use it as an excuse to write off the next young woman with a big idea I also don’t want Bad Blood to scare people away from next gen diagnostics Theranos went to extraordinary lengths to get around quality standards The industry is highly regulated and new diagnostics undergo rigorous testing Bad Blood tackles some serious ethical questions but it is ultimately a thriller with a tragic ending It’s a fun read full of bizarre details that will make you gasp out loud The story almost feels too ridiculous to be real at points no wonder Hollywood is already planning to turn it into a movie I think it’s the perfect book to read by the fire this winter